Robert P Gaynes
Overview
Explore the profile of Robert P Gaynes including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
1248
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gopalsamy S, Ramakrishnan A, Shariff M, Gabel J, Brennan S, Drenzek C, et al.
Open Forum Infect Dis
. 2021 Oct;
8(10):ofab473.
PMID: 34660837
Automated identification systems may misidentify , the causative agent of brucellosis, which may be re-emerging in the United States as the result of an expanding feral swine population. We present...
2.
Clinical relevance of metronidazole and peripheral neuropathy: a systematic review of the literature
Goolsby T, Jakeman B, Gaynes R
Int J Antimicrob Agents
. 2017 Sep;
51(3):319-325.
PMID: 28887203
The objective of this paper was to review and evaluate the literature on metronidazole-associated peripheral neuropathy and determine the relevance in clinical practice. MEDLINE/PubMed, EBSCO, and Google Scholar were searched...
3.
Kabbani S, Jacob J, Gaynes R, Rimland D
Am J Infect Control
. 2016 Jan;
44(4):488-90.
PMID: 26717870
Despite the recent focus on prevention of health care-associated infections, rates of Candida bloodstream infections in adults have remained unchanged until recently. We report a decline of Candida bloodstream infections,...
4.
Reddy S, Jacob J, Varkey J, Gaynes R
Expert Rev Anti Infect Ther
. 2015 May;
13(7):843-54.
PMID: 25925531
A majority of patients hospitalized in the US hospitals receive an antibiotic during their hospitalization. Furthermore, up to half of antibiotics prescribed in hospitals are inappropriate. In the setting of...
5.
Weston G, Jacob J, Ray S, Varkey J, Gaynes R
Infect Control Hosp Epidemiol
. 2013 Nov;
34(12):1324-6.
PMID: 24225621
No abstract available.
6.
Stone N, Lewis D, Johnson 2nd T, Hartney T, Chandler D, Byrd-Sellers J, et al.
Infect Control Hosp Epidemiol
. 2012 May;
33(6):551-7.
PMID: 22561709
Objective: To identify risk factors associated with methicillin-resistant Staphylococcus aureus (MRSA) acquisition in long-term care facility (LTCF) residents. Design: Multicenter, prospective cohort followed over 6 months. Setting: Three Veterans Affairs...
7.
Jacob J, Gaynes R
Expert Rev Anti Infect Ther
. 2010 Aug;
8(8):893-902.
PMID: 20695745
Three major trends in antibiotic use in US hospitals have emerged over the last few years: antibiotics as quality metrics, persistent use of different measures of antibiotic consumption and the...
8.
9.
McAllister L, Gaynes R, Rimland D, McGowan Jr J
Infect Control Hosp Epidemiol
. 2010 Mar;
31(5):538-40.
PMID: 20334507
Our case-control study sought to identify risk factors for colonization with methicillin-resistant Staphylococcus aureus (MRSA) at hospital admission among patients with no known healthcare-related risk factors. We found that patients...
10.
Gaynes R, Gould C, Edwards J, Antoine T, Blumberg H, DeSilva K, et al.
Infect Control Hosp Epidemiol
. 2009 Jun;
30(8):794-6.
PMID: 19530943
We examined interventions to optimize piperacillin-tazobactam use at 4 hospitals. Interventions for rotating house staff did not affect use. We could target empiric therapy in only 35% of cases. Because...